Boston, MA 的 血液疾病 臨床試驗
10 項針對 血液疾病 的研究正在 Boston(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
正在為研究招募對象嗎?將此頁面置頂展示 — $99 / 30 天 →
Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
招募中
- Massachusetts General Hospital, Boston
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Massachusetts General Hospital, Boston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
招募中2 期
- Dana-Farber Cancer Institute, Boston
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Massachusetts General Hospital, Boston
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
招募中1/2 期歡迎健康志工
- Massachusetts General Hospital, Boston
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
招募中1 期
- Massachusetts General Hospital, Boston
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
招募中觀察性研究
- Massachusetts General Hospital Comprehensive Hemophilia and Thrombosis Treatment Center, Boston
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
招募中2/3 期
- Dana-Farber Cancer Institute, Boston
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
招募中
- Massachusetts General Hospital Cancer Center, Boston
HEME Home Transfusion Program
招募中
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
其他城市的 血液疾病 試驗
- Atlanta, GA10 項研究
- Houston, TX9 項研究
- Los Angeles, CA9 項研究
- The Bronx, NY8 項研究
- New York City, NY7 項研究
- Nashville, TN7 項研究
- Mountain View, CA6 項研究
- Durham, NC5 項研究
- Portland, OR5 項研究
- Washington, DC5 項研究
- Seattle, WA5 項研究
- Greenville, NC5 項研究
Boston 的其他研究
- 乳癌111 項研究
- 非小細胞肺癌90 項研究
- 癌症(所有類型)86 項研究
- 大腸直腸癌63 項研究
- 轉移性癌症63 項研究
- 肺癌62 項研究
- 卵巢癌61 項研究
- 前列腺癌59 項研究
- 憂鬱症52 項研究
- 子宮內膜癌50 項研究
- 心臟衰竭44 項研究
- 急性髓系白血病44 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月5日。各研究自行設定資格標準;由研究團隊決定參與者資格。